Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms

Cholesterol 7α-hydroxylase (CYP7A1) plays a key role in maintaining lipid and bile salt homeostasis as it is the rate-limiting enzyme converting cholesterol to bile acids. Deficiency of CYP7A1 leads to hyperlipidemia in man and mouse. Hyperlipidemia is often seen in patients when treated with high-dose retinoic acid (RA), but the molecular mechanisms remain elusive. Our present study revealed that CYP7A1 mRNA expression is greatly repressed by RA in both human hepatocytes and HepG2 cells where increased fibroblast growth factor 19 (FGF19) and small heterodimer partner (SHP) expressions were also observed, suggesting farnesoid X receptor (FXR) and retinoid X receptor (RXR) were activated. Promoter reporter assays demonstrate that all-trans RA (atRA) specifically activated FXR/RXR. However, detailed molecular analyses indicate that this activation is through RXR, whose ligand is 9-cis RA. Knocking down of FXR or RXRα by small interference RNA (siRNA) in human hepatocytes increased CYP7A1 basal expression, but the repressive effect of atRA persisted, suggesting there are also FXR/RXR-independent mechanisms mediating atRA repression of CYP7A1 expression. Chromatin immunoprecipitation (ChIP) assay and cell transfection results indicate that PGC-1α plays a role in the FXR/RXR-independent mechanism. Our findings may provide a potential explanation for hyperlipidemic side effects observed in some patients treated with high-dose RA.

[1]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[2]  F. Gonzalez,et al.  Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. , 2003, Gastroenterology.

[3]  J. Chiang,et al.  Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha). , 2003, Gene.

[4]  J. Chiang.  Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. , 2004, Journal of hepatology.

[5]  J. Chiang,et al.  Farnesoid X Receptor Responds to Bile Acids and Represses Cholesterol 7 a-Hydroxylase Gene ( CYP 7 A 1 ) Transcription * , 2000 .

[6]  R. Rando,et al.  Isomerization of all-trans-retinoic acid to 9-cis-retinoic acid. , 1994, The Biochemical journal.

[7]  J. Boyer,et al.  ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. , 2009, Gastroenterology.

[8]  Jasmine Chen,et al.  Identification of Gene-selective Modulators of the Bile Acid Receptor FXR* , 2003, The Journal of Biological Chemistry.

[9]  N. de Pedro,et al.  The Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion* , 2004, Journal of Biological Chemistry.

[10]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[11]  J. Chiang,et al.  Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.

[12]  D. Mangelsdorf,et al.  A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR , 2002, Science.

[13]  J. Chiang,et al.  Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. , 2006, Hepatology.

[14]  J. Chiang,et al.  Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. , 2000, Journal of lipid research.

[15]  J. Berenguer,et al.  Increase in serum total cholesterol and low-density lipoprotein cholesterol by high-dose chenodeoxycholic acid in patients with radiolucent gallstones significantly reversed during preventive low dose after gallstone dissolution. , 1985, Digestion.

[16]  J. Chiang,et al.  Bile acids and cytokines inhibit the human cholesterol 7α‐hydroxylase gene via the JNK/c‐jun pathway in human liver cells , 2006 .

[17]  G. Kullak-Ublick,et al.  The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism. , 2006, Molecular endocrinology.

[18]  T. Shih,et al.  Nonenzymatic isomerization of 9-cis-retinoic acid catalyzed by sulfhydryl compounds. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[19]  M. Makishima,et al.  The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. , 2001, Gastroenterology.

[20]  M. Ananthanarayanan,et al.  Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice Published, JLR Papers in Press, February 16, 2003. DOI 10.1194/jlr.M200489-JLR200 , 2003, Journal of Lipid Research.

[21]  T. O'Leary,et al.  Changes in serum lipoproteins and high-density lipoprotein composition during isotretinoin therapy. , 1987, Clinical and investigative medicine. Medecine clinique et experimentale.

[22]  D. Cassio,et al.  Investigation of the hepatotoxicity profile of chemical entities using Liverbeads and WIF-B9 in vitro models. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[23]  D. Mangelsdorf,et al.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. , 2000, Science.

[24]  Rama Ranganathan,et al.  Structural Determinants of Allosteric Ligand Activation in RXR Heterodimers , 2004, Cell.

[25]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[26]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[27]  T. Osborne,et al.  PGC-1alpha activates CYP7A1 and bile acid biosynthesis. , 2003, The Journal of biological chemistry.

[28]  K. Faber,et al.  Low retinol levels differentially modulate bile salt–induced expression of human and mouse hepatic bile salt transporters , 2009, Hepatology.

[29]  S. Kliewer,et al.  Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine Published, JLR Papers in Press, August 24, 2007. , 2007, Journal of Lipid Research.

[30]  N. Le,et al.  Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. , 1985, New England Journal of Medicine.

[31]  S. Vavricka,et al.  The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-α and -β genes , 2006 .

[32]  P. Nilsson-ehle,et al.  In Vivo Effects of 13-cis Retinoic Acid Treatment on the Concentration of Proteins and Lipids in Serum , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[33]  T. Willson,et al.  Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. , 2001, Molecular endocrinology.

[34]  M. Brelsford,et al.  Preventing and managing the side effects of isotretinoin. , 2008, Seminars in cutaneous medicine and surgery.

[35]  S. Kliewer,et al.  Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. , 2003, Genes & development.

[36]  J. Chiang,et al.  Peroxisome proliferator-activated receptor a (PPAR a ) and agonist inhibit cholesterol 7 a -hydroxylase gene ( CYP7A1 ) transcription , 2000 .

[37]  J. Chiang,et al.  Farnesoid X Receptor Responds to Bile Acids and Represses Cholesterol 7α-Hydroxylase Gene (CYP7A1) Transcription* , 2000, The Journal of Biological Chemistry.

[38]  P. Young,et al.  Retinoid X Receptor (RXR) Agonist-induced Antagonism of Farnesoid X Receptor (FXR) Activity due to Absence of Coactivator Recruitment and Decreased DNA Binding* , 2003, The Journal of Biological Chemistry.

[39]  J. Boyer,et al.  The farnesoid X receptor FXRalpha/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolution. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[40]  Celeste Eng,et al.  Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. , 2002, The Journal of clinical investigation.

[41]  R. Savkur,et al.  Regulation of carbohydrate metabolism by the farnesoid X receptor. , 2005, Endocrinology.

[42]  S. Strom,et al.  Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α‐hydroxylase gene expression , 2009, Hepatology.

[43]  M. Makishima,et al.  Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor* , 2001, The Journal of Biological Chemistry.

[44]  J. Chiang,et al.  Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4α (HNF4α) , 2003 .

[45]  J. Zerwekh,et al.  Disruption of Cholesterol 7α-Hydroxylase Gene in Mice , 1996, The Journal of Biological Chemistry.

[46]  T. A. Kerr,et al.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.

[47]  W. Leyden,et al.  A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. , 2006, Archives of dermatology.

[48]  H. Gronemeyer,et al.  Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function , 2007, Proceedings of the National Academy of Sciences.

[49]  S. Vavricka,et al.  The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[50]  R. Stravitz,et al.  Transcriptional regulation of cholesterol 7 alpha-hydroxylase mRNA by conjugated bile acids in primary cultures of rat hepatocytes. , 1993, The Journal of biological chemistry.

[51]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[52]  J. Zerwekh,et al.  Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. , 1996, The Journal of biological chemistry.

[53]  B. Staels,et al.  FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. , 2003, Gastroenterology.

[54]  J. Lehmann,et al.  Activation of the orphan receptor RIP14 by retinoids. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Kemper,et al.  Ligand-activated Pregnane X Receptor Interferes with HNF-4 Signaling by Targeting a Common Coactivator PGC-1α , 2004, Journal of Biological Chemistry.

[56]  T. Osborne,et al.  PGC-1α Activates CYP7A1 and Bile Acid Biosynthesis* , 2003, Journal of Biological Chemistry.

[57]  N. Swanson,et al.  Etretinate therapy causes increases in lipid levels in patients with psoriasis. , 1982, Archives of dermatology.

[58]  Gregor Eichele,et al.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.

[59]  R. Evans,et al.  Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.